EDITORIAL
Published on 10 Jun 2024
Editorial: Novel in-vitro and in-vivo strategies to study pancreatic ductal adenocarcinoma progression and chemoresistance
doi 10.3389/fcell.2024.1435209
- 523 views
- 1 citation
- Frontiers in Cell and Developmental Biology
- Cancer Cell Biology
- Research Topics
- Novel in-Vitro and in-Vivo Strategies to Study Pancreatic Ductal Adenocarcinoma Progression and Chemoresistance
Novel in-Vitro and in-Vivo Strategies to Study Pancreatic Ductal Adenocarcinoma Progression and Chemoresistance
4,577
Total downloads
13k
Total views and downloads
Articles
CASE REPORT
Published on 13 Feb 2024
Case report: Diverse immune responses in advanced pancreatic ductal adenocarcinoma treated with immune checkpoint inhibitor-based conversion therapies
doi 10.3389/fimmu.2024.1326556
- 828 views
BRIEF RESEARCH REPORT
Published on 05 Feb 2024
Hypoxia at 3D organoid establishment selects essential subclones within heterogenous pancreatic cancer
doi 10.3389/fcell.2024.1327772
- 2,582 views
- 4 citations
ORIGINAL RESEARCH
Published on 15 Sep 2023
Laminin 332 expression levels predict clinical outcomes and chemotherapy response in patients with pancreatic adenocarcinoma
doi 10.3389/fcell.2023.1242706
- 3,385 views
- 6 citations
CASE REPORT
Published on 13 Oct 2022
Case Report: Anlotinib combined with PD-1 inhibitor and sequential GA regimen or FOLFIRINOX Chemotherapy in treatment of KRAS G12V mutated pancreatic ductal adenocarcinoma with liver metastasis: A case and literature review
doi 10.3389/fimmu.2022.1016647
- 2,732 views
- 9 citations
